EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients

Inez Schoenmakers, William D Fraser

JAMA · 2024

DOI: 10.1001/jama.2024.6839 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Inez Schoenmakers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Denosumab, Hypocalcemia, Kidney Failure, Chronic. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsDenosumabHypocalcemiaKidney Failure, ChronicRenal DialysisAgedFemaleHumansMaleMiddle AgedCalcium

Substanzen

Bone Density Conservation AgentsCalciumDenosumab

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom.

Zitieren

APA

Schoenmakers, I., & Fraser, W. D. (2024). Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients. JAMA. https://doi.org/10.1001/jama.2024.6839

Vancouver

Schoenmakers I, Fraser WD. Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients. JAMA. 2024. doi:10.1001/jama.2024.6839

BibTeX
@article{Schoenmakers2024,
  author = {Schoenmakers, Inez and Fraser, William D},
  title = {Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.6839}
}
Kostenlos starten →